analysts and calls -- B of A | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
analysts and calls -- B of A

An SI Board Since September 2002

Posts	SubjectMarks	Bans
33	11	0

Emcee: scaram(o)uche	Type: Moderated

Introduction Compact

Who are the current biotech analysts at Banc of America, and what are their calls?

In five years, this may be a resource. Please feel free to comment on their OLD calls at BofA or other institutions.

I will occasionally update this subject post to (1) reflect the current team, or (2) point at guys/gals when they screw up, take their millions, and head for a hedge fund (etc.).

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
33	Bank of America Expands Equity Research Coverage with Addition of Biotech Analys	scaram(o)uche	-	6/21/2007
32	A Second Look: Acadia Pharma Associated Press 03.20.07, 11:18 AM ET Shares of A	sim1	-	3/20/2007
31	UPDATE 1-RESEARCH ALERT-BofA starts five biopharmaceutical cos Wed Nov 1, 2006 6	sim1	-	11/2/2006
30	Two Picks In Big Pharma Ahead Of Q3 Earnings <i>BTW, Saw Cramer on Pharma	Doc Bones	-	10/13/2005
29	BofA Starts Genentech With Buy By TSC Staff 8/19/2005 8:17 AM EDT Docto	Doc Bones	-	8/22/2005
28	Banc of America Securities Hires David Witzke as an Equity Research Analyst Cove	scaram(o)uche	-	3/22/2005
27	I assume they mean the CAGR of revenues. Given that a small biotech's reven	tom pope	-	1/15/2005
26	Just CYA. Must frustrate the heck out of the analyst. Too bad.... leaving s	scaram(o)uche	-	1/15/2005
25	I agee - this is silly in just so many ways. Looking at CAGR in the first place	Biomaven	-	1/15/2005
24	Several of us have bemoaned that lack of coverage, post-Enron era, of small caps	scaram(o)uche	-	1/15/2005
23	Message 20570422	scaram(o)uche	-	9/29/2004
22	[Ok, Ok - we were a little bit unlucky there. How about 73 dollars?] 6:12 pm Ge	Icebrg	-	5/19/2003
21	This may very well become a "classic". <i>:29AM Genentech cut	Icebrg	-	5/19/2003
20	Friedman, Billings, Ramsey Announces Addition to Healthcare Analyst Team Monday	scaram(o)uche	-	5/12/2003
19	Banc of America Securities Hires Award Winning Health Care Team From CSFB Tuesda	scaram(o)uche	-	3/25/2003
18	Yeah, but he only covers such large stuff (cap) these days, that it's sort o	scaram(o)uche	-	12/26/2002
17	intresting site geocities.com cheers S one can select MK predictions	dalroi	-	12/26/2002
16	Yup. I agree. I feel that the early clinical and preclinical stuff is addressi	scaram(o)uche	-	11/17/2002
15	If I look at the way the market is valuing pre-clinical/clincal stuff (i.e. CRF)	mopgcw	-	11/17/2002
14	Thanks! B of A has a good new junior analyst now, too. As a matter of fact, he	scaram(o)uche	-	11/16/2002
13	Rick, I don't think NBIX was covered by BOFA before King. I will check b	JFitnich	-	11/16/2002
12	>> "And it is time for you ro redeploy your new cash into exciting ju	scaram(o)uche	-	11/15/2002
11	Well, the guy covers nbix, ceph and gilead. He is dead right to say lighten up.	keokalani'nui	-	11/15/2002
10	Even the best of the analysts are now traders. (yeah, I was also wondering if N	scaram(o)uche	-	11/15/2002
9	On Michael King: BTW, was that he or another analyst who downgraded NBIX from s	hmpa	-	11/15/2002

Go to reply# or date (mm/dd/yy):